Related Experiment Videos

Idiopathic atrial flutter in infancy: a review of eight cases

Pediatrics
|January 1, 1978
PubMed

Insights

Digoxin effectively treats atrial flutter in infants without heart issues. For infants with cardiac decompensation, DC countershock is recommended over quinidine.

Area of Science:

  • Pediatric Cardiology
  • Electrophysiology

Background:

  • Atrial flutter is a significant arrhythmia in infants.
  • Management strategies for infant atrial flutter without congenital heart disease require clear guidelines.

Purpose of the Study:

  • To review institutional experiences in managing atrial flutter in infants under two years old.
  • To evaluate the efficacy and safety of different therapeutic approaches, including digoxin and quinidine.

Main Methods:

  • Retrospective review of three institutions' management of atrial flutter in infants.
  • Analysis of treatment outcomes for infants receiving digoxin versus those requiring DC cardioversion or quinidine.

Main Results:

  • Digoxin led to uncomplicated resolution in five neonates with atrial flutter.
  • One infant treated with digoxin experienced prolonged paroxysmal supraventricular tachycardia.
  • Two older infants required DC cardioversion after quinidine substitution for digoxin therapy.

Conclusions:

  • Digoxin remains the preferred initial therapy for non-acutely ill infants with atrial flutter.
  • DC countershock is indicated for infants exhibiting signs of cardiac decompensation.

Related Concept Videos